UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000033265
Receipt No. R000037721
Official scientific title of the study Impact of neoplasm to vancomycin trough concentrations ~Preliminary investigation targeting the entire concentration range of vancomycin trough value~
Date of disclosure of the study information 2018/07/15
Last modified on 2018/07/04 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Impact of neoplasm
to vancomycin trough concentrations
~Preliminary investigation targeting the entire concentration range of vancomycin trough value~
Title of the study (Brief title) Impact of neoplasm
to vancomycin trough concentrations
Region
Japan

Condition
Condition Infection with MRSA
Classification by specialty
Infectious disease
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Comparison of the Vancomycin trough value by the cancer species
Basic objectives2 Pharmacokinetics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes We compared the difference of the trough value by the cancer species
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
999 years-old >
Gender Male and Female
Key inclusion criteria To be written
Key exclusion criteria To be written
Target sample size 78

Research contact person
Name of lead principal investigator Shoko HASEGAWA
Organization Shujitsu University
Division name Faculty of Pharmacy
Address 1-6-1 Nishigawara, Naka-ku, Okayama,Japan
TEL 086-271-8409
Email teshima@shujitu.ac.jp

Public contact
Name of contact person Daisuke TESHIMA
Organization Shujitsu University
Division name Faculty of Pharmacy
Address 1-6-1 Nishigawara, Naka-ku, Okayama,Japan
TEL 086-271-8409
Homepage URL
Email teshima@shujitu.ac.jp

Sponsor
Institute Shujitsu University
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 07 Month 15 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 04 Month 15 Day
Anticipated trial start date
2016 Year 04 Month 15 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information To be written

Management information
Registered date
2018 Year 07 Month 04 Day
Last modified on
2018 Year 07 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037721